Dae‐Won Lee

1.5k total citations
46 papers, 842 citations indexed

About

Dae‐Won Lee is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Dae‐Won Lee has authored 46 papers receiving a total of 842 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Dae‐Won Lee's work include Genetic factors in colorectal cancer (7 papers), Breast Cancer Treatment Studies (7 papers) and Advanced Breast Cancer Therapies (6 papers). Dae‐Won Lee is often cited by papers focused on Genetic factors in colorectal cancer (7 papers), Breast Cancer Treatment Studies (7 papers) and Advanced Breast Cancer Therapies (6 papers). Dae‐Won Lee collaborates with scholars based in South Korea, United States and Ethiopia. Dae‐Won Lee's co-authors include Kyung-Hun Lee, Sae‐Won Han, Gyeong Hoon Kang, Seung‐Yong Jeong, Seock‐Ah Im, Kyu Joo Park, Tae‐You Kim, Jeong Mo Bae, Jae‐Kyung Won and Sean P. McDonough and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Dae‐Won Lee

46 papers receiving 837 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dae‐Won Lee South Korea 14 426 281 176 162 158 46 842
Shu‐Chen Huang Taiwan 12 283 0.7× 166 0.6× 97 0.6× 94 0.6× 197 1.2× 20 772
Sean Agbor-Enoh United States 17 204 0.5× 326 1.2× 63 0.4× 230 1.4× 510 3.2× 80 1.2k
Sandra A. Drigo Brazil 21 133 0.3× 309 1.1× 147 0.8× 180 1.1× 90 0.6× 36 858
Ned Z. Carp United States 13 283 0.7× 120 0.4× 151 0.9× 82 0.5× 109 0.7× 26 685
Olagunju Ogunbiyi United Kingdom 11 419 1.0× 263 0.9× 151 0.9× 43 0.3× 373 2.4× 18 1.2k
Masatoshi Deguchi Japan 14 110 0.3× 257 0.9× 48 0.3× 73 0.5× 128 0.8× 42 643
Steven Sieber United States 15 152 0.4× 174 0.6× 124 0.7× 121 0.7× 129 0.8× 38 630
Wenche Reed Norway 17 282 0.7× 139 0.5× 94 0.5× 181 1.1× 132 0.8× 25 681
H Saitoh Japan 13 162 0.4× 209 0.7× 61 0.3× 146 0.9× 61 0.4× 35 740
P Fouret France 15 257 0.6× 228 0.8× 229 1.3× 130 0.8× 71 0.4× 38 777

Countries citing papers authored by Dae‐Won Lee

Since Specialization
Citations

This map shows the geographic impact of Dae‐Won Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dae‐Won Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dae‐Won Lee more than expected).

Fields of papers citing papers by Dae‐Won Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dae‐Won Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dae‐Won Lee. The network helps show where Dae‐Won Lee may publish in the future.

Co-authorship network of co-authors of Dae‐Won Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Dae‐Won Lee. A scholar is included among the top collaborators of Dae‐Won Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dae‐Won Lee. Dae‐Won Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, So Hyeon, Young Joo Park, Ahrum Min, et al.. (2025). DNA damage and Nuclear Anaplasia Induced by Trastuzumab Deruxtecan in Cancer Cells with Variable HER2 Expression and Homologous Recombination Deficiency Status. Cancer Research and Treatment. 1 indexed citations
2.
Won, Young‐Woong, Jin‐Hyoung Kang, Jung Hye Kwon, et al.. (2023). A Multicenter, Prospective, Observational Study to Evaluate Ethanol-Induced Symptoms in Patients Receiving Docetaxel Chemotherapy. Cancer Research and Treatment. 55(4). 1096–1103. 1 indexed citations
3.
Kim, Soo‐Yeon, et al.. (2023). Prediction of Tumor Progression During Neoadjuvant Chemotherapy and Survival Outcome in Patients With Triple-Negative Breast Cancer. Korean Journal of Radiology. 24(7). 626–626. 4 indexed citations
4.
Kim, Kwangsoo, Jeong Mo Bae, Dae‐Won Lee, et al.. (2023). Mutations of TP53 and genes related to homologous recombination repair in breast cancer with germline BRCA1/2 mutations. Human Genomics. 17(1). 2–2. 12 indexed citations
5.
Lee, Dae‐Won, et al.. (2023). Recent Developments in the Therapeutic Landscape of Advanced or Metastatic Hormone Receptor–Positive Breast Cancer. Cancer Research and Treatment. 55(4). 1065–1076. 4 indexed citations
6.
Chang, Euijin, Song Yi Park, Dae‐Won Lee, et al.. (2022). Evaluation of Seropositivity After Standard Doses of Vaccination Against SARS-CoV-2 in Patients With Early Breast Cancer Receiving Adjuvant Treatment. The Oncologist. 27(12). e931–e937. 2 indexed citations
7.
Jeon, Sun Kyung, Se Hyung Kim, Cheong‐Il Shin, et al.. (2022). Role of Dedicated Subspecialized Radiologists in Multidisciplinary Team Discussions on Lower Gastrointestinal Tract Cancers. Korean Journal of Radiology. 23(7). 732–732. 5 indexed citations
8.
Kim, Jin Yong, Chan Mi Lee, Dae‐Won Lee, et al.. (2022). Prospective longitudinal analysis of antibody response after standard and booster doses of SARS-COV2 vaccination in patients with early breast cancer. Frontiers in Immunology. 13. 1028102–1028102. 3 indexed citations
9.
Park, Yeon Hee, Seock‐Ah Im, Kyunghee Park, et al.. (2021). Prospective longitudinal multi-omics study of palbociclib resistance in hormone receptor+/HER2- metastatic breast cancer.. Journal of Clinical Oncology. 39(15_suppl). 1013–1013. 8 indexed citations
10.
Yang, Yaewon, Ahrum Min, Kyung-Hun Lee, et al.. (2020). Prognostic Role of Androgen Receptor Expression in Surgically Resected Early Breast Cancer Patients. Journal of Breast Cancer. 23(2). 182–182. 9 indexed citations
11.
Lee, Dae‐Won, Sooyoung Cho, Aesun Shin, Sae‐Won Han, & Tae‐You Kim. (2020). Body mass index and body weight change during adjuvant chemotherapy in colon cancer patients: results from the AVANT trial. Scientific Reports. 10(1). 19467–19467. 13 indexed citations
12.
Yang, Bo Ram, Myoung‐jin Jang, Miso Kim, et al.. (2020). Association of Insulin, Metformin, and Statin with Mortality in Breast Cancer Patients. Cancer Research and Treatment. 53(1). 65–76. 9 indexed citations
13.
Kim, Jung Youn, Dae‐Won Lee, Kyung-Hun Lee, et al.. (2019). Prognostic role of body mass index is different according to menopausal status and tumor subtype in breast cancer patients. Breast Cancer Research and Treatment. 176(2). 453–460. 7 indexed citations
14.
Lee, Dae‐Won, Sae‐Won Han, Jeong Mo Bae, et al.. (2018). Association Between Fusobacterium nucleatum, Pathway Mutation, and Patient Prognosis in Colorectal Cancer. Annals of Surgical Oncology. 25(11). 3389–3395. 81 indexed citations
15.
Bae, Jeong Mo, Jung Ho Kim, Yoonjin Kwak, et al.. (2017). Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system. British Journal of Cancer. 116(8). 1012–1020. 38 indexed citations
16.
Lee, Dae‐Won, Kyung-Hun Lee, Tae‐Yong Kim, et al.. (2016). Prognostic Role of Body Mass Index in Advanced Small Bowel Adenocarcinoma Patients Receiving Palliative Chemotherapy. Nutrition and Cancer. 68(5). 750–755. 1 indexed citations
17.
Cha, Yongjun, Kyung-Ju Kim, Sae‐Won Han, et al.. (2016). Adverse prognostic impact of the CpG island methylator phenotype in metastatic colorectal cancer. British Journal of Cancer. 115(2). 164–171. 37 indexed citations
18.
Lee, Dae‐Won, Sae‐Won Han, Yongjun Cha, et al.. (2015). Different prognostic effect of CpG island methylation according to sex in colorectal cancer patients treated with adjuvant FOLFOX. Clinical Epigenetics. 7(1). 63–63. 17 indexed citations
19.
Lee, Dae‐Won, Sae‐Won Han, Yongjun Cha, et al.. (2015). Prognostic influence of body mass index and body weight gain during adjuvant FOLFOX chemotherapy in Korean colorectal cancer patients. BMC Cancer. 15(1). 690–690. 9 indexed citations
20.
Han, Sae‐Won, Hwang-Phill Kim, Jong-Yeon Shin, et al.. (2014). RNA editing in RHOQ promotes invasion potential in colorectal cancer. The Journal of Experimental Medicine. 211(4). 613–621. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shu‐Chen Huang Breakdown of academic impact, for papers by Sean Agbor-Enoh Breakdown of academic impact, for papers by Sandra A. Drigo Breakdown of academic impact, for papers by Ned Z. Carp Breakdown of academic impact, for papers by Olagunju Ogunbiyi Breakdown of academic impact, for papers by Masatoshi Deguchi Breakdown of academic impact, for papers by Steven Sieber Breakdown of academic impact, for papers by Wenche Reed Breakdown of academic impact, for papers by H Saitoh Breakdown of academic impact, for papers by P Fouret
Rankless by CCL
2026